Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.
Latest news
Novosanis turns 8!
12/03/2021
What a milestone! 8 years and counting. To celebrate our 8th anniversary, we asked our team members to describe Novosanis and their experience in unique words. Teamwork and Innovation were in the top 2. Thank you to everyone who has been part of this journey!
Latest blogpost
Upcoming event
Eurogin 2021
Düsseldorf, Germany
Novosanis is excited to have a booth at EUROGIN, an international conference focusing on Human Papillomavirus (HPV). We look forward to speaking with you and discussing the potential of urine sampling in HPV detection through our innovative medical device, Colli-Pee.